Validation of a Portable Sleep Device in Patients With Co-existing Medical Illnesses

Not Applicable

Completed

• Conditions: OSA
• Interventions: Device: NOX T3

• Registration Number: NCT03930316
• Lead Sponsor: Chinese University of Hong Kong

Brief Summary

The standard sleep study for diagnosing obstructive sleep apnea (OSA) in patients with co-existing illness is by conducting an attended polysomnography (PSG) with more than 7 channels for recording physiological parameters in the sleep center, as recommended by international guidelines. However the guidelines are more than 10 year old without update. With the growing and aging of the population, there is a need to explore if portable monitoring devices could be used in this group of population, so this group of patients can be managed in a timely manner. Portable monitoring devices have been used widely in patients without significant co-existing illness. These devices record at least 4 physiological parameters for diagnosing OSA and can be performed in an unattended setting e.g. at home because of the simplicity. This can shorten the waiting time for making a diagnosis using PSG.

Eighty patients suspected of OSA, with stable co-existing illnesses, will be recruited for the study. Informed consent will be signed before participation. They will be offered a standard attended PSG in the sleep center. A portable monitoring device "Nox T3" will be hooked up to the patients concurrently during the PSG.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-01
• Study First Submitted: 2019-04-16
• Study First Submitted QC: 2019-04-25
• Study First Posted: 2019-04-29
• Primary Completion: 2021-12-31
• Study Completion: 2021-12-31
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-29
• Last Update Posted: 2023-08-31

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

• Adult patients suspect of OSA (with or without symptoms) of age between 18 to 80 years old, with or without significant comorbidities.
• Patients consent of concurrent use of both type I and or type III devices at the same time in hospital setting.

Exclusion Criteria

• Pregnant patients.
• Patients refuse to have both type I and type III devices used concurrently.
• Patients with any co-existing medical illnesses which are unstable. "Unstable" is defined as:
• Any recent hospital admission within 1 month before the schedule of sleep study
• Any recent change of medication within 1 month before the schedule of sleep study
• Any change in patient conditions requiring medical attention within 1 month before the schedule of sleep study.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
observation	NOX T3	validation of observational arm

Primary Outcome Measures

Name	Time	Method
To assess the accuracy of the new portable sleep study device with reference to concurrent PSG.	1 year	compare the AHI of NOX T3 with reference to PSG

Trial Locations

Locations (1)

Department of Medicine and Therapeutics, Prince of Wales Hospital, CUHK; 🇭🇰 Shatin, Hong Kong